COMMENT MEURT-ON DE LA MALADIE DE HODGKIN EN 1979. (ETUDE A PARTIR DE 102 DECES)CASASSUS PHILIPPE.1979; ; FRA; DA. 1979; 150 P.; 30 CM; BIBL. 146 REF.; TH.: MED./PARIS 5/1979/153Thesis

Le dépistage du cancer de la prostate est-il bénéfique ?CASASSUS, Philippe.Médecine (Montrouge). 2009, Vol 5, Num 8, pp 355-358, issn 1777-2044, 4 p.Article

L'imàtinib (Glivec®) : une révolution dans le traitement de la leucémie myéloïde chronique (LMC)CASASSUS, Philippe.MT. Médecine thérapeutique. 2005, Vol 11, Num 6, pp 428-436, issn 1264-6520, 9 p.Article

Quelles sont les limites des indications et de la poursuite des thérapeutiques lourdes ? : Exemple de la chimiothérapie anticancéreuse = What are the limits of the indications and applications of major therapies?: The example of anticancer chemotherapyCASASSUS, Philippe.Thérapie (Paris). 2004, Vol 59, Num 2, pp 243-245, issn 0040-5957, 3 p.Conference Paper

Que faut-il espérer ou craindre des vaccins anti-papillomavirus ? = What should we hope or fear of HPV vaccines?CASASSUS, Philippe.Médecine (Montrouge). 2012, Vol 8, Num 2, pp 61-65, issn 1777-2044, 5 p.Article

Hématologie: données nouvelles 2009CASASSUS, Philippe.Médecine (Montrouge). 2010, Vol 6, Num 3, pp 107-108, issn 1777-2044, 2 p.Article

Une histoire de la transfusionCASASSUS, Philippe.Médecine (Montrouge). 2009, Vol 5, Num 2, pp 90-93, issn 1777-2044, 4 p.Article

Anémie par carence en fer. 2e partie : Dossier AnémiesCASASSUS, Philippe.La Revue du praticien. Médecine générale. 2007, Num 754-55, pp 35-38, issn 0989-2737, 4 p.Article

Anémie = AnaemiaCASASSUS, Philippe.La Revue du praticien (Paris). 2004, Vol 54, Num 16, pp 1801-1809, issn 0035-2640, 9 p.Article

Anémie par carence martiale : Etiologie, physiopathologie, diagnostic, traitement avec la posologie du traitement martial = Anaemia of iron deficiencyCASASSUS, Philippe.La Revue du praticien (Paris). 2001, Vol 51, Num 2, pp 209-213, issn 0035-2640Article

Méthotrexate et polyarthrite rhumatoïdeCASASSUS, Philippe.Médecine (Montrouge). 2009, Vol 5, Num 1, pp 11-15, issn 1777-2044, 5 p.Article

Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: A phase 2a studyPAUL, Carle; SANS, Beatrix; GINESTE, Paul et al.American journal of hematology. 2010, Vol 85, Num 12, pp 921-925, issn 0361-8609, 5 p.Article

Le cœur du métier de soignant en hématologie = At the core of professional practice in hematologyBAUCHETET, Chantal; BORDESSOULE, Dominique; JOUET, Jean-Pierre et al.Hématologie (Montrouge). 2011, Vol 17, Num 3, pp 243-247, issn 1264-7527, 5 p.Article

Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS groupGRESSIN, Rémy; CAULET-MAUGENDRE, Sylvie; LEPEU, Gérard et al.Haematologica (Roma). 2010, Vol 95, Num 8, pp 1350-1357, issn 0390-6078, 8 p.Article

Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome : Analysis of four prospective trials including 278 patientsGAYRAUD, Martine; GUILLEVIN, Loïc; LE TOUMELIN, Philippe et al.Arthritis and rheumatism. 2001, Vol 44, Num 3, pp 666-675, issn 0004-3591Article

Soutenir les enfants de parents touchés par le cancer = Support for children of parents suffering from cancer. ILIU, Mathias; MORERE, Jean-François; VERNOIS, Sylvie et al.Soins. Pédiatrie, puériculture. 2013, Num 270, pp 42-45, issn 1259-4792, 4 p.Article

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapyFACON, Thierry; MARY, Jean-Yves; HAROUSSEAU, Jean-Luc et al.Blood. 2006, Vol 107, Num 4, pp 1292-1298, issn 0006-4971, 7 p.Article

Treatment of adult systemic mastocytosis with interferon-α: results of a multicentre phase II trial on 20 patientsCASASSUS, Philippe; CAILLAT-VIGNERON, Nadine; GUILLEVIN, Loïc et al.British journal of haematology. 2002, Vol 119, Num 4, pp 1090-1097, issn 0007-1048, 8 p.Article

Superiority of the Triple Combination of Bortezomib-Thalidomide-Dexamethasone Over the Dual Combination of Thalidomide-Dexamethasone in Patients With Multiple Myeloma Progressing or Relapsing After Autologous Transplantation: The MMVAR/IFM 2005-04 Randomized Phase III Trial From the Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationGARDERET, Laurent; IACOBELLI, Simona; MILONE, Giuseppe et al.Journal of clinical oncology. 2012, Vol 30, Num 20, pp 2475-2482, issn 0732-183X, 8 p.Article

Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95SIMON, Audrey; PEOCH, Michel; VILQUE, Jean Pierre et al.British journal of haematology. 2010, Vol 151, Num 2, pp 159-166, issn 0007-1048, 8 p.Article

Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma : final results of the prospective and randomized IFM 99-04 protocolMOREAU, Philippe; HULLIN, Cyrille; BERTHOU, Christian et al.Blood. 2006, Vol 107, Num 1, pp 397-403, issn 0006-4971, 7 p.Article

Comparison of 200 mg/m² melphalan and 8 Gy total body irradiation plus 140 mg/m² melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trialMOREAU, Philippe; FACON, Thierry; JAUBERT, Jérome et al.Blood. 2002, Vol 99, Num 3, pp 731-735, issn 0006-4971Article

Genetic abnormalities and survival in multiple myeloma : the experience of the Intergroupe Francophone du Myélome. CommentaryFONSECA, Rafael; AVET-LOISEAU, Hervé; GARDERET, Laurent et al.Blood. 2007, Vol 109, Num 8, issn 0006-4971, 3132-3133,3489-3495 [9 p.]Article

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06) : a randomised trialFACON, Thierry; YVES MARY, Jean; DIB, Mamoun et al.Lancet (British edition). 2007, Vol 370, Num 9594, pp 1209-1218, issn 0140-6736, 10 p.Article

Thalidomide versus placebo in myeloid metaplasia with myelofibrosis : a prospective, randomized, double-blind, multicenter studyABGRALL, Jean-Franpois; GUIBAUD, Isabelle; RODON, Philippe et al.Haematologica (Roma). 2006, Vol 91, Num 8, pp 1027-1032, issn 0390-6078, 6 p.Article